Dr. Robert Garry

Robert F. Garry, Jr., Ph.D.

Professor
Department of Microbiology & Immunology 
Tulane University Health Sciences Center
1430 Tulane Avenue, SL-38 
New Orleans, LA, 70112
Phone: (504) 988-2027
rfgarry@tulane.edu

Bio

Robert F. Garry is a Professor in the Department of Microbiology and Immunology at Tulane University School of Medicine in New Orleans. He serves in the Tulane University administration as Assistant Dean for Graduate Studies in Biomedical Sciences, directing a large multidisciplinary training program. Research in the Garry Laboratory focuses on a number of aspects of viral pathogenesis. He was involved in collaborative studies that lead to the determination that entry proteins of enveloped viruses form at least three distinct structural classes.

Dr. Garry continues to maintain a broad interest in the mechanisms of enveloped virus entry. He has a long-standing interest in viral diagnostics dating back to his work with the industry scientists who developed the first generation of ELISA and western blot assays to detect serum antibodies to HIV-1. These early studies on viral diagnostics lead to his characterization of an isolate of HIV from a patient who died of AIDS in 1969, the earliest confirmed case of AIDS in the United States. He is currently managing the consortium of scientists who are developing modern diagnostics for several biodefense pathogens.

Selected publications

• Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
  Branco LM, Grove JN, Geske FJ, Boisen ML, Muncy IJ, Magliato SA, Henderson LA, Schoepp RJ, Cashman KA, Hensley LE, Garry RF.
  Virol J. 2010 Oct 20;7:279.
• Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects
  Branco LM, Grove JN, Moses LM, Goba A, Fullah M, Momoh M, Schoepp RJ, Bausch DG, Garry RF.
  Virol J. 2010 Nov 9;7(1):306.
• Down-regulation of cell surface CXCR4 by HIV-1.
  Choi B, Gatti PJ, Fermin CD, Vigh S, Haislip AM, Garry RF.
  Virol J. 2008 Jan 11;5:6.
• Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein
  Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.
  Virus Res. 2006 Sep;120(1-2):146-55. Epub 2006 Apr 17.
• Preventing neonatal HIV: a review
  Jaspan HB, Garry RF.
  Curr HIV Res. 2003 Jul;1(3):321-7. Review.
• Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders
  Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Cao Y, Sander DM, Shoenfeld Y, Ahmed A, Van de Water J, Gershwin ME, Garry RF.
  Lancet. 1998 May 30;351(9116):1620-4. Erratum in: Lancet 1998 Jul 11;352(9122):152.
• Alteration of intracellular potassium and sodium concentrations correlates with induction of cytopathic effects by human immunodeficiency virus
  Voss TG, Fermin CD, Levy JA, Vigh S, Choi B, Garry RF.
  J Virol. 1996 Aug;70(8):5447-54.
• Detection of a human intracisternal A-type retroviral particle antigenically related to HIV
  Garry RF, Fermin CD, Hart DJ, Alexander SS, Donehower LA, Luo-Zhang H.
  Science. 1990 Nov 23;250(4984):1127-9.